One interpretation of these results could be that the high expression of the NPL gene in the low-risk group promotes the prognosis of cervical cancer patients by regulating the protein degradation signaling pathway, catalyzing the cleavage of sialic acid, and thereby reducing the expression of sialic acid in cervical cancer tissues. Here, NPL is linked to cervical cancer.